Delivery Order SPE2DB20D1004-SPE2DB22FF8Y3
Award Date 7/11/22
Potential Completion Date 7/12/22
Potential Value $1.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,323.66 delivery order is for Insulin Lispro 100 Unit/mL Pen 3mL, a pharmaceutical product used for diabetes management. The contract has a ceiling value of $1,323.66 and is a firm fixed-price delivery order, with a completion date of July 25, 2023. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
- This federal contract award, valued at $1,057.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Lispro 100 Unit/mL Vial 10mL, a critical pharmaceutical product used in the management of diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.08 firm fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL, a critical medication used to manage diabetes. The award does not have a set-aside designation, indicating open competition. The contract is a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL at a firm fixed price of $1,036.86. The contract has a period of performance through March 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL. The contract is a delivery order valued at $5,219.28 with a firm fixed price. The award date was February 24, 2022, and the ultimate completion date is February 25, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,029.72 firm fixed-price delivery order is for the supply of INSULIN LISPRO 100 UNIT/ML PEN 3ML, with a completion date of December 21, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL. The contract has a ceiling value of $1,198.85 and a period of performance through April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,057.47 delivery order is for the supply of insulin lispro 100 unit/mL pens, a critical medication for diabetes management. The contract has a firm fixed price and runs until September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a diabetes medication. The contract has a firm fixed price of $1,190.81 and an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program and is open competition. Amerisourcebergen Drug Corp is the prime...